Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2016, Article ID 4208156, 7 pages
http://dx.doi.org/10.1155/2016/4208156
Research Article

Longitudinal Frequencies of Blood Leukocyte Subpopulations Differ between NOD and NOR Mice but Do Not Predict Diabetes in NOD Mice

1Institute for Diabetes and Obesity, Helmholtz Zentrum München, Ingolstädter Landstrasse 1, 85764 Neuherberg, Germany
2Institute of Diabetes Research, Helmholtz Zentrum München and Forschergruppe Diabetes, Klinikum rechts der Isar, Technische Universität München, Ingolstädter Landstrasse 1, 85764 Neuherberg, Germany
3German Mouse Clinic, Institute of Experimental Genetics, Helmholtz Zentrum München, Ingolstädter Landstrasse 1, 85764 Neuherberg, Germany
4Institute for Medical Microbiology, Immunology and Hygiene, Technical University of Munich, Trogerstraße 30, 81675 Munich, Germany
5German Center for Diabetes Research (DZD), Ingolstädter Landstrasse 1, 85764 Neuherberg, Germany
6Forschergruppe Diabetes e.V., Ingolstädter Landstrasse 1, 85764 Neuherberg, Germany
7School of Life Science Weihenstephan, Technical University of Munich, Alte Akademie 8, 85354 Freising, Germany
8Institute for Systemic Inflammation Research, University of Lübeck, Ratzeburger Allee 160, 23538 Lübeck, Germany
9DFG Research Center for Regenerative Therapies Dresden, Medical Faculty, Technische Universität Dresden, Fetscherstrasse 105, 01307 Dresden, Germany

Received 6 November 2015; Accepted 31 December 2015

Academic Editor: Paolo Fiorina

Copyright © 2016 Tanja Telieps et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. S. Anderson and J. A. Bluestone, “The NOD mouse: a model of immune dysregulation,” Annual Review of Immunology, vol. 23, pp. 447–485, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. M. A. Atkinson and E. H. Leiter, “The NOD mouse model of type 1 diabetes: as good as it gets?” Nature Medicine, vol. 5, no. 6, pp. 601–604, 1999. View at Publisher · View at Google Scholar · View at Scopus
  3. P. Pozzilli, A. Signore, A. J. K. Williams, and P. E. Beales, “NOD mouse colonies around the world—recent facts and figures,” Immunology Today, vol. 14, no. 5, pp. 193–196, 1993. View at Publisher · View at Google Scholar · View at Scopus
  4. I. Marrero, A. Vong, Y. Dai, and J. D. Davies, “T cell populations in the pancreatic lymph node naturally and consistently expand and contract in NOD mice as disease progresses,” Molecular Immunology, vol. 52, no. 1, pp. 9–18, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. E. Mariño, M. Batten, J. Groom et al., “Marginal-zone B-cells of nonobese diabetic mice expand with diabetes onset, invade the pancreatic lymph nodes, and present autoantigen to diabetogenic T-cells,” Diabetes, vol. 57, no. 2, pp. 395–404, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. K. Koczwara, M. Schenker, S. Schmid, K. Kredel, A.-G. Ziegler, and E. Bonifacio, “Characterization of antibody responses to endogenous and exogenous antigen in the nonobese diabetic mouse,” Clinical Immunology, vol. 106, no. 2, pp. 155–162, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. E. Bonifacio, M. Atkinson, G. Eisenbarth et al., “International Workshop on Lessons From Animal Models for Human Type 1 Diabetes: identification of insulin but not glutamic acid decarboxylase or IA-2 as specific autoantigens of humoral autoimmunity in nonobese diabetic mice,” Diabetes, vol. 50, no. 7–12, pp. 2451–2458, 2001. View at Publisher · View at Google Scholar · View at Scopus
  8. V. Gailus-Durner, H. Fuchs, T. Adler et al., “Systemic first-line phenotyping,” Methods in Molecular Biology, vol. 530, pp. 463–509, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. J. D. Singer and J. B. Willett, Applied Longitudinal Data Analysis: Modeling Change and Event Occurrence, Oxford University Press, 2003.
  10. H. Akaike, “A new look at the statistical model identification,” IEEE Transactions on Automatic Control, vol. 19, pp. 716–723, 1974. View at Google Scholar · View at MathSciNet
  11. W. S. Cleveland, E. Grosse, and W. M. Shyu, “Local regression models,” in Statistical Models in S, Wadsworth & Brooks/Cole, 1992. View at Google Scholar
  12. E. Melanitou, D. Devendra, E. Liu, D. Miao, and G. S. Eisenbarth, “Early and quantal (by litter) expression of insulin autoantibodies in the nonobese diabetic mice predict early diabetes onset,” Journal of Immunology, vol. 173, no. 11, pp. 6603–6610, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. A. G. Ziegler, M. Rewers, O. Simell et al., “Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children,” The Journal of the American Medical Association, vol. 309, no. 23, pp. 2473–2479, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Schlosser, R. Wassmuth, M. Strebelow, I. Rjasanowski, and M. Ziegler, “Multiple and high-titer single autoantibodies in schoolchildren reflecting the genetic predisposition for type 1 diabetes,” Annals of the New York Academy of Sciences, vol. 1005, pp. 98–108, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. E. Bonifacio, “Predicting type 1 diabetes using biomarkers,” Diabetes Care, vol. 38, no. 6, pp. 989–996, 2015. View at Publisher · View at Google Scholar
  16. S. P. Berzins, E. S. Venanzi, C. Benoist, and D. Mathis, “T-cell compartments of prediabetic NOD mice,” Diabetes, vol. 52, no. 2, pp. 327–334, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. J.-M. Gombert, A. Herbelin, E. Tancrède-Bohin, M. Dy, C. Carnaud, and J.-F. Bach, “Early quantitative and functional deficiency of NK1+-like thymocytes in the NOD mouse,” European Journal of Immunology, vol. 26, no. 12, pp. 2989–2998, 1996. View at Publisher · View at Google Scholar · View at Scopus
  18. P. Fiorina, A. Vergani, S. Dada et al., “Targeting CD22 reprograms b-cells and reverses autoimmune diabetes,” Diabetes, vol. 57, no. 11, pp. 3013–3024, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Arif, P. Leete, V. Nguyen et al., “Blood and islet phenotypes indicate immunological heterogeneity in type 1 diabetes,” Diabetes, vol. 63, no. 11, pp. 3835–3845, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. N. Abiru, L. Yu, D. Miao et al., “Transient insulin autoantibody expression independent of development of diabetes: comparison of NOD and NOR strains,” Journal of Autoimmunity, vol. 17, no. 1, pp. 1–6, 2001. View at Publisher · View at Google Scholar · View at Scopus